Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 15/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 14/20 | 0.48 |
| ▸ | GAA | P10253 | 10/20 | 0.48 |
| ▸ | RAB9A | P51151 | 5/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.48 |
| ▸ | NPC1 | O15118 | 4/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25417584 | 1.00 | MAPT (0.48) | MAPTALDH1A1GAARAB9ASMN1; SMN2 | |
| SCHEMBL25414769 | 0.79 | ALDH1A1 (0.43) | MAPTALDH1A1GAARAB9ASMN1; SMN2 | |
| SCHEMBL25169589 | 0.74 | MAPT (0.48) | MAPTALDH1A1GAARAB9ASMN1; SMN2 | |
| SCHEMBL11337596 | 0.69 | MAPT (0.59) | MAPTALDH1A1GAARAB9ASMN1; SMN2 | |
| SCHEMBL15591983 | 0.65 | TERT (0.51) | MAPTALDH1A1RAB9ASMN1; SMN2NPC1 | |
| SCHEMBL9804049 | 0.62 | MAPT (0.63) | MAPTALDH1A1GAARAB9ASMN1; SMN2 | |
| SCHEMBL8573847 | 0.62 | MAPT (0.63) | MAPTALDH1A1GAARAB9ASMN1; SMN2 | |
| Bromide SCHEMBL29599463 | 0.60 | MAPT (0.61) | MAPTALDH1A1GAARAB9ASMN1; SMN2 | |
| SCHEMBL3971710 | 0.60 | ALDH1A1 (0.67) | MAPTALDH1A1GAARAB9ASMN1; SMN2 | |
| SCHEMBL25414210 | 0.60 | ALDH1A1 (0.50) | MAPTALDH1A1GAARAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260071117-A1 | FUNABLE FLUORESCENT COMPOUNDS AND USES THEREOF | UNIV ARIZONA (US) | 2026-03-12 | — | — | US | disclosed |
| WO-2023081261-A1 | TUNABLE FLUORESCENT COMPOUNDS AND USES THEREOF | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2023-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071117-A1 | FUNABLE FLUORESCENT COMPOUNDS AND USES THEREOF | H1-3, NISCH, H1-2 | MAPT 3635/4885ALDH1A1 2028/4885GAA 4639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.